| Item | Content |
|---|---|
| Rating | Neutral |
| Target price (base-case fair range) | HK$24 – 32 |
| Current price | HK$27.40 (2026-10-30 close, frozen price anchor) |
| Probability-weighted expected value | ~HK$28.5 (+4.0% vs. current price) |
| Margin of safety (vs. base-case fair floor) | -12.4% (current price above the base-case floor of HK$24) |
| Time horizon | 12 months |
| Market cap / total shares | HK$25.074 billion / 915.1 million shares (post full H-share circulation) |
| Last report | 2026-07-14: Cautiously bullish, target price HK$45–65 |
| Item | Last (2026-07-14) | This (2026-10-31) | Reason for change |
|---|---|---|---|
| Stance | Cautiously bullish | Neutral | After a -43% share price decline, the current price has fallen within this report's base-case fair range (HK$24–32); margin of safety shifted from -6% to -12.4%. The prior target price was built on an FY2026 revenue assumption of RMB 2.0–2.4 billion; actual 2026H1 revenue of RMB 834 million missed the implied H1 anchor (RMB 1.0–1.2 billion) by 16.6%–30.5%, leading to an overall downward revision of the revenue base |
| Confidence | 0.50 | 0.45 | Interim revenue below consensus; key KPIs such as capacity utilization ceased to be quantitatively disclosed from the interim report; quality of operating cash flow turnaround is questionable |
| Target price range | HK$45–65 | HK$24–32 | FY2026E revenue RMB 1.75–1.95 billion (prior 2.0–2.4 billion), FY2027E RMB 2.4–2.8 billion (prior 3.5–4.2 billion); exit P/S lowered from 8–9x to 7.5–9x (recalibrated against mature peers at 5–6x and growth premium) |
| Valuation judgment | Fair | Fair | Maintained — last time the price was near the lower bound of the base range; this time it sits mid-range; no systematic mispricing in either case |
Key new facts in this report (occurred since last report): ① 2026-08-28 interim results: revenue RMB 834 million (+50.6%) below Bloomberg consensus; gross margin 11.6%; operating cash flow +RMB 169 million, the first positive half-year since listing; ② MSCI August quarterly review: not included (prior report's core catalyst falsified); ③ CFO change (Zhong Shan stepping down, Wei Yu appointed) disclosed the same day as an event involving deviation of raised funds into wealth-management products; ④ Navitas and NVIDIA jointly developed a second-generation 24kW 800V power board, showcased at OCP 2026; Infineon announced an €1.1 billion investment to build the world's first 300mm GaN volume-production fab (production by end-2027); ⑤ SK group sold 66.9% of its stake in January; the CMB group gained a channel for ~191 million shares to circulate after full H-share convertibility; ⑥ Hang Seng TECH Index expansion consultation launched.
We downgrade Innoscience from the prior cautiously bullish stance to Neutral. Over the past three and a half months the share price fell 42.8% to HK$27.40 (2026-10-30 close); valuation has retreated from the prior "fair-to-rich" level to within this report's base-case fair range (HK$24–32) — pessimistic expectations are largely priced in, but the stock has not yet fallen to a level of absolute cheapness that requires no growth narrative for support.
The fundamentals present "real improvement coexisting with questionable quality": revenue +50.6%, gross margin 11.6%, and the first positive half-year operating cash flow since listing are all first-hand verified facts; however, interim revenue missed consensus, ~RMB 205 million of the cash flow turnaround came from increases in payables (including a new notes payable instrument of RMB 118 million), and the RMB 172 million inventory increase was almost entirely concentrated in finished goods; the ~15% full-year gross margin guidance implies H2 must reach 17.4%–17.9% (roughly 7x the prior year's seasonal slope).
On valuation, P/B of ~5.6x and market cap are both at their lowest percentile since the December 2024 listing; the direction that "the growth rate implied by the current price has been halved" holds, but the magnitude depends on exit multiple assumptions — at a mature power-semiconductor 3x P/S exit, the current price implies a 2026–2030 revenue CAGR of ~39% (not pessimistic). The pivot between bull and bear cases hinges on the timing of NVIDIA's Kyber rack 800V HVDC volume ramp in 2027 and whether the company secures formal purchase orders: the company's positioning in the NVIDIA ecosystem currently lags Navitas by roughly one product generation, the most important reason we dare not maintain a bullish view this time.
Share supply (the CMB group's ~20.9% of the free float; the chairman's lock-up expiring 2027-01-22) and refinancing dilution (management CapEx guidance ~RMB 1.0 billion in 2026 and RMB 1.0–2.0 billion in 2027) continue to suppress valuation recovery. Recommendation: do not chase at current levels, nor sell into the decline; use NVIDIA's formal PO and FY2026 annual gross margin (H2 above 17.4%) as right-side confirmation signals; reassess if the price breaks below HK$24 or bear-case evidence becomes explicit.
In one sentence: The stock trades at its lowest valuation percentile since listing, with the implied four-year forward revenue growth rate down to roughly half the industry's; 2026Q4–2027Q1 offers a triple confirmation window of capacity installation, NVIDIA's formal PO, and annual-report gross margin — a left-side opportunity in odds-structure terms, but key forward indicators (capacity utilization ~120%, year-end installed capacity 30–35k wafers/month, full-year gross margin ~15%) all come from earnings-call minutes rather than announcements, and the interim report stopped quantitatively disclosing capacity KPIs, limiting evidence strength.
Expectation gap: The market is pricing a combination of pessimism — "volume ramp delayed + breakeven postponed + supply and dilution" — not a collapse of the GaN narrative; this diverges from marginal improvements such as high capacity utilization, AI data center shipments +183%, and positive operating cash flow. But the counter-constraints are equally clear: a loss-making stock has no earnings floor, and the sell-side target price spectrum (HK$74.2–114), more than 171% above the current price, represents a duration mismatch; moreover, that spectrum has a track record of systematic optimism on this name. The expectation gap favors greater upside convergence potential than downside, but realization depends on NVIDIA's decision timing, which is exogenous to the company.
Primary share-price drivers, ranked: ① NVIDIA's formal 800VDC order (determines the shift in valuation from "narrative discount" to "order-based pricing"); ② annual-report validation of gross margin and the 2027 breakeven path; ③ share supply and refinancing pace.
Validation and falsification: Validation — updates to the NVIDIA directory/MGX whitelist; a company-voluntary announcement of a formal supply agreement; FY2026 annual gross margin ≥14% with a reaffirmed breakeven. Falsification — no formal PO by 2027Q2 with Navitas/Infineon winning design wins first; annual gross margin <14%; a single-quarter concentrated sale of 30-million-share magnitude or a discounted placement.
This report's counter-scenario: if Infineon's 300mm ramps on schedule, the ~30% unit cost advantage of 8-inch over 6-inch would narrow to within one generation, and competition would revert to system-level integration and customer qualification dimensions.
Table: Key Financial Data (RMB 100 million; 2026H1 is the latest period)
| Metric | FY2023 | FY2024 | FY2025 | 2026H1 |
|---|---|---|---|---|
| Revenue | 5.93 | 8.28 | 12.13 | 8.34 |
| YoY | — | +39.8% | +46.4% | +50.6% |
| Gross margin | ~-6.1% | -19.5% | +7.3% | +11.6% |
| Gross margin excl. inventory write-back | — | — | ~2.3% | ~10.4% |
| Net profit attributable to shareholders | -11.03 | -10.46 | ~-8.41* | -3.09 |
| Adjusted net loss (Non-IFRS) | — | -8.36 | -6.76 | -2.66 |
| Operating cash flow | -5.94 | -3.36 | -8.06 | +1.69 |
| Free cash flow (OCF−CapEx calculation) | — | — | -10.17 | -2.30 |
| Cash-like assets (cash + large CDs + pledged deposits, period-end) | — | — | 25.23 | 24.86 |
| Interest-bearing debt (period-end) | — | — | 22.30 | 26.03 |
| Gearing ratio | — | — | — | 46.9% |
| Inventory (period-end) | — | 4.44 | 8.97 | 10.69 |
| Chip shipments | — | 660 million units | 800 million units | 547 million units |
| Per-unit ASP (calculated) | — | ~RMB 1.26 | ~RMB 1.52 | ~RMB 1.52 |
* The FY2025 attributable net loss of ~RMB 841 million is a calculated figure cross-checked via the operating cash flow/net loss ratio of 0.96 and the cash flow statement. FX basis: RMB 1 = HK$1.1796 (2026-10-31 cross rate), applied consistently throughout; market cap of HK$25.074 billion ≈ RMB 21.26 billion.
Reasons for metric changes (items with YoY ≥ ±20%, with company explanations): ① CapEx 0.50→398 million (+690%), company explanation "purchase of capacity expansion equipment, continuing to advance capacity expansion," with capital commitments on hand rising from 159 million to 700 million; ② operating cash flow swung from -387 million to +169 million, company explanation "continued revenue growth, improved profitability, and higher operational efficiency" — but per the notes breakdown, payables increases contributed ~205 million (including a new notes payable instrument of 118 million); excluding these, ~-36 million; ③ administrative expenses -33.2%, company explanation "reduction in share-based payment expenses and professional fees" (SBC fell from 88.34 million to 42.72 million); ④ finance costs -39.4%, company explanation "optimized financing structure to lower interest rates"; ⑤ loans and borrowings +373 million, company explanation "purchase of production equipment to expand production scale"; ⑥ overseas revenue -42% YoY (36.97 million), unexplained by the company — consistent with the timing of the ITC exclusion order taking effect; ⑦ related-party sales rose from 368,000 to 8.517 million (~23x), unexplained by the company; ⑧ contract liabilities +171.7% vs. start of year, unexplained by the company.
2026H1 overview: Revenue RMB 834 million (+50.6%), of which high-value markets (AI data centers/industrial & energy storage/automotive/robotics) RMB 532 million (+70%, 63.9% of total), consumer electronics RMB 301 million (+26%, 36.2% of total); gross margin 11.6% (+4.8pp YoY); net loss attributable to shareholders RMB 309 million (narrowed by 27.9%); adjusted net loss RMB 266 million; OCF +RMB 169 million. Continued product mix upgrade: module revenue +74.4% (share rose to 49.4%), wafers +73.5% (volume ramp at strategic cooperation customers such as ST/onsemi), discrete devices & ICs only +11.1%.
Results reconciliation (vs. our own forecasts in the previous report dated 2026-07-14): The prior forecast assumed FY2026 revenue of RMB 2.0–2.4 billion (implying H1 of RMB 1.0–1.2 billion) — H1 actual was RMB 834 million, 16.6% below the low end and roughly 24% below the midpoint. The miss was mainly driven by decelerating consumer electronics growth (+26% vs. our +25–30% assumption, broadly in line) and an overly low revenue base for AI data centers (shipments +183%, but the FY2025 base was only RMB 63 million), indicating that the conversion from "high shipment growth" to "high revenue growth" suffers from per-unit value dilution; gross margin of 11.6% fell below the bottom of the prior 12–15% expectation range; OCF turning positive (+RMB 169 million) beat our prior expectation of "net outflow narrowing to under RMB 400 million," but the quality is discounted upon dissection. Conclusion: the prior revenue assumptions were systematically optimistic by roughly 17–31%; we have now cut FY2026E to RMB 1.75–1.95 billion and FY2027E to RMB 2.4–2.8 billion.
Management guidance vs. market expectations: The company maintains its full-year gross margin target of ~15% and net profit breakeven in 2027 (per earnings call minutes; the interim report outlook was only qualitative and noticeably more vague than the multiple quantitative commitments in the FY2025 annual report, such as "volume production in 2026"). CMB International cut its FY2027 revenue forecast by 18.2% on September 2. Whether the company "beats expectations" must be adjudicated by the 2027 annual report: a full-year 15% gross margin implies 17.4%–17.9% in H2 — a challenging target.
Business model in brief: Asset-heavy 8-inch GaN-on-Si IDM (two fabs in Suzhou and Zhuhai; full chain of epitaxy–wafer–discrete devices–IC–modules), with 99.9% of revenue from product sales recognized at a point in time, with no recurring/subscription component. Strong bargaining power upstream (silicon substrates/gallium raw materials), weak bargaining power downstream in consumer (OEM concentration + price comparison), currently strong bargaining power in AI data centers (scarce qualified suppliers) but set to decline after 2027 as five suppliers come on stream. Weak pricing power; mix upgrade (rising module/wafer share) is the actual mechanism for ASP increases.
Cash content of earnings: OCF/net loss ratio during loss periods: FY2023/24/25/2026H1 of 0.54/0.32/0.96/positive turn on a negative denominator — improving trend, but the 2026H1 turnaround relies on payables-type instruments; FCF has been negative for consecutive years (FY2025 –RMB 1.017 billion, 2026H1 –RMB 230 million). Recurring profitability basis: the adjusted net loss (FY2025 –RMB 676 million) adds back SBC of RMB 164 million in full — an aggressive treatment, as SBC is a recurring annual expense; conversely, the attributable loss contains no one-off gains window-dressing. Government subsidies in FY2025 totaled RMB 68.96 million for the full year, ~10% of the adjusted loss — profit improvement has a mild dependence on subsidies.
Return on capital: ROIC is negative (FY2025 roughly –9.9%, NOPAT roughly –RMB 640 million / invested capital roughly RMB 6.44 billion) — a loss-making investment phase; hard-cash validation of the moat must await completion of the gross margin ramp.
CapEx quality: 2026H1 CapEx/depreciation & amortization = 1.62x (RMB 398 million / RMB 246 million), capacity expansion restarting; the company does not disclose a split between maintenance and growth capex, but high capacity utilization (per minutes, ~120%) implies incremental spending is essentially growth investment — the risk lies not in a "black hole" but in front-loaded depreciation if demand disappoints (heavy-asset depreciation per 10k wafers/month installed will weigh on gross margin as the ramp proceeds).
Red flags: ① Largest customer accounts for 31.7% and top five for 48.35%, both up vs. FY2024; ② inventory of RMB 1.069 billion, 14.7% of total assets, with slow finished-goods turnover; NRV reversals continue despite cumulative provisions of RMB 180 million — direction skews optimistic; ③ cash runway: cash-like assets of RMB 2.486 billion ÷ annualized adjusted loss of ~RMB 530 million ≈ 4.7 years, but against annualized CapEx of RMB 800 million–1.0 billion and RMB 700 million of committed obligations, if H2 operating cash flow fails to stay positive while expansion runs at full speed, refinancing may be needed in 2027–2028.
Words-vs-deeds consistency: Three verifiable commitment-delivery pairs — ① "expand capacity to 20,000 wafers/month" (FY2024 annual report outlook) → achieved by end-2025, delivered; ② "En-FCLGA packaged 100V series in volume production in 2026" (FY2025 annual report) → 2026H1 saw scaled delivery to multiple leading server/power-supply makers, HVDC chip shipments +183%, delivered; ③ "senseGaN integrated chip volume ramp in 2026" (FY2025 annual report) → not mentioned again in the interim report, unverified. Overall verdict: "partially delivered; pragmatic in tone but never provides quantitative guidance" — outlooks are all qualitative, with no revenue or gross margin targets, so delivery can only be pieced together ex post. Note one negative signal: the interim report outlook is noticeably more vague than the FY2025 annual report language (multiple "volume production in 2026" commitments disappeared).
Shareholder friendliness: No dividends during the loss period ("no reserves available for distribution") and no company-level buyback/cancellation; the share award trust purchases shares from the market (482万 cumulative shares) for incentive purposes, not shareholder returns. Significant dilution history: December 2024 IPO net proceeds of HK$1.352 billion plus 2025 placements netting ~HK$2.09 billion (new shares ~+3.9%) — verdict: "neutral, leaning unfriendly"; financing cadence follows expansion needs rather than restraint around share-price windows (the two placements were at discounts of ~9%/8% respectively).
Risk signals: ① CFO Zhong Shan's term expiry and departure was disclosed on the same day as the interim report and the wealth-management deviation announcement (new CFO Wei Yu has a capital-markets background and only joined in May 2026); ② RMB 1.315 billion of IPO proceeds were sequentially used to purchase large-denomination certificates of deposit/wealth-management products — a temporary deviation from the stated use with delayed disclosure; the company itself admitted "an unintentional error… insufficient reporting and verification mechanisms" — a procedural internal-control blemish, since remediated (redemption and redeposit completed before end-September 2026); ③ related-party sales (Xingyao Semiconductor, controlled by the controlling shareholder) grew ~23x in six months to RMB 8.52 million, unexplained; ④ full board reshuffle in September 2026. None of these items is large individually, but directionally they constitute a governance discount factor.
The company's statutory reporting segment is a single GaN power semiconductor segment; the following is management's split by application and product (gross margins by application are not disclosed).
Table: Split by application (revenue share)
| Application | FY2025 | 2026H1 | YoY (2026H1) | Business logic in one sentence |
|---|---|---|---|---|
| Consumer electronics (fast charging/appliances, etc.) | 46.8% (RMB 568m) | 36.2% (RMB 301m) | +26% | Base business: amortizes capacity costs through volume; price wars suppress ASP |
| Industrial & energy storage | 42.9% (RMB 521m) | High-value markets combined 63.9% (RMB 532m) | Sales +83% | Current growth driver: home storage/C&I storage/BMS/motor drive ramp |
| AI & data centers | 5.2% (RMB 63m) | (in high-value) | Shipments +183% | 800V HVDC ecosystem positioning; largest value elasticity, still small in absolute terms |
| NEVs (incl. LiDAR) | ~9.0% (RMB 109m) | (in high-value) | Automotive shipments +103% | OBC/DC-DC in mass production on vehicles; extending from peripheral to core power |
| Humanoid robots | 0.1% | (in high-value) | Shipments +50% | Early commercialization; positioning play |
By product form (2026H1): modules 49.4% (RMB 412m, +74.4%) / wafers 22.5% (RMB 187m, +73.5%) / discrete devices & ICs 27.6% (RMB 230m, +11.1%) — a marked migration vs. FY2025 (modules 36.8%/wafers 20.9%/discrete ICs 42.0%) toward higher-integration forms. Profit driver assessment: the company does not disclose segment gross margins, so the profit driver cannot be directly located via "revenue share × gross margin"; however, module and wafer revenue (aimed at strategic cooperation customers such as ST/onsemi) grew 6–7x faster than discrete devices, and the company explicitly attributes gross margin improvement to "a rising share of high-margin products," from which we infer profit improvement is mainly driven by modules + wafers. Structural implication: wafer revenue is essentially foundry-like in nature (onsemi MoU, ST agreement); its gross margin exceeds modules', but customer stickiness depends on agreement duration — the rising "foundry-ization" of the revenue mix cuts both ways.
Accounting red flags: ① Large swings in inventory write-down "provision–reversal" (severity: medium) — provision of RMB 116 million in the FY2024 IPO year depressed the base; FY2025 reversal of RMB 61.20 million contributed 5.0pp to gross margin (only 2.3% excluding it); 2026H1 saw a further reversal of RMB 10.62 million (~1.2pp contribution); ② deviation of raised funds from stated use + delayed disclosure (severity: medium) — RMB 1,165 million in CDs was approved within the CFO's authority without board approval, exposing a missing reporting/verification mechanism (the company says principal-protected with no loss; remediated); ③ abnormal growth in related-party sales (severity: low) — sales to an entity controlled by the controlling shareholder rose 23x in six months, unexplained; ④ elevated inventory alongside reversals (severity: medium) — finished goods of RMB 785 million, turnover ~263 days (annualized), far above peers; reversals continue despite cumulative provisions of RMB 180 million.
Cross-period consistency: ① Inventory turnover days 164→291→~263 days (FY2024→FY2025→2026H1); inventory +141% over 18 months, far outpacing revenue growth — unexplained by the company; ② operating cash flow diverged from net loss trends (FY2025: loss narrowed but OCF deteriorated 1.4x, working capital consumed RMB 710 million; then a sudden swing to positive in 2026H1) — attribution inconsistent across periods; ③ two gross-margin jumps (–19.5%→7.3%→11.6%): disclosed attributions (scale effects + cost reduction) never mention reversal contributions — inconsistent; ④ contract liabilities swung in a V shape (RMB 93.12m→RMB 19.04m→RMB 51.73m) — unexplained by the company; ⑤ largest-customer concentration 22.0%→31.7% — unexplained by the company.
Overall judgment: Based on the 2026 interim report and FY2025 annual report extracted here, no profit-fabrication-level accounting tactics were found; however, the gap between inventory accounting and the apparent gross margin improvement, plus the fundraising internal-control blemish, warrant applying a 1–2pp haircut to the "gross margin ramp" narrative — the 2026H1 ex-reversal gross margin of 10.4% used in this report's valuation embodies that haircut.
Current market data (anchor frozen at 2026-10-30 close): Share price HK$27.40 (–7.1% on the day, a 52-week low); market cap HK$25.074 billion; P/B ~5.6x, P/S (TTM) ~14.2x, FY2026E forward P/S ~10.6–12.1x — all at post-IPO lows (percentile sample ~22 months, for reference only). P/E not applicable (loss period; earnings not representative). Liquidity: average daily turnover of ~HK$146 million over the past 31 trading days (~0.58% of market cap) — liquidity is normal.
Table: Peer comparison (market caps and multiples as of noted dates)
| Company | Positioning | Revenue scale/growth | Gross margin | P/S (TTM) |
|---|---|---|---|---|
| Innoscience | 8-inch GaN IDM leader | TTM RMB 1.49bn / +50.6% | 11.6% | ~14.2x |
| Navitas (NVTS) | GaN pure-play + 800V option | TTM ~US$36.5m / 2026Q2 –27.6% | Non-GAAP 39.5% | ~66.8x (down 66% from peak) |
| Power Integrations | High-voltage GaN, steady profits | FY2025 US$444m / +5.9% | 53–55% | ~6–9x |
| Wolfspeed (cautionary precedent) | SiC inflection-falsification case | FY2024 US$833m / –9.6% | Loss-making | ~4.2x post-falsification (2024-03) |
| Infineon | Global No.1 in power / 300mm threat | GaN share <1% | ~40% (group) | 3–5x range (group; not a precise comp) |
What the market has already priced in: Backing out from exit P/S (base: 2026E revenue midpoint of RMB 1.9bn) — at 3x exit in 2030 (mature power semiconductors), revenue of RMB 7.09bn is needed, implying a CAGR of ~39%; at 5x, RMB 4.25bn, CAGR ~22.3%; at 8x, RMB 2.66bn, CAGR ~8.7%. One-sentence verdict: the current price does not imply a "collapse of the GaN narrative," but rather a combination of pessimism — "growth downshifting to half the industry rate + delayed breakeven + dilution." Whether this holds depends on whether the company deserves a P/S above 5x by 2030, i.e., whether gross margin can climb into the 20%+ growth-company range. Two-sided check: Upside — high capacity utilization, TTM +50.6%, industry CAGR of 42–44% supporting undiminished growth; downside — Navitas –66% from peak, Wolfspeed's P/S collapsing from 20–30x to 4.2x post-falsification; AI power-supply option pricing is tightening globally.
Three-tier value (EPV): Asset value ~HK$4.99/share (equity of RMB 3.872bn at end-2026H1 ÷ 915.1 million shares; replacement cost basis even thinner at ~HK$2.6/share); EPV — with the company's adjusted annual loss at ~RMB 530 million, operations are not self-sustaining under a zero-growth assumption, so EPV has no economic meaning and is set at 0; the current price is almost entirely supported by the growth option (asset floor is only ~18%). Reference basis post-breakeven: 2028E normalized EBITDA of RMB 1.3bn × 10x EV/EBITDA (mature power semiconductor range), discounted to ~HK$13.8/share — even if breakeven is delivered in 2027, half the value at the current price still hinges on growth delivered after 2028. The valuation is essentially a bet on the pace of HVDC delivery; that is this stock's pricing structure, not a buy or sell reason in itself.
Table: Three scenarios and odds (12-month horizon)
| Scenario | Probability | Fair value range (HK$) | vs. current price | Key assumptions |
|---|---|---|---|---|
| Bear | 25% | 9 – 15 (midpoint 12) | –67% ~ –45% | HVDC 2027 volume ramp falsified + Infineon 300mm ramps on schedule + consumer price war keeps gross margin stuck below 15% + delayed breakeven triggers a placement (on ~1,007 million post-dilution shares: 2027E revenue of RMB 2.0–2.2bn × P/S 4–6x) |
| Base | 52% | 24 – 32 (midpoint 28) | –12.4% ~ +16.8% | 2026 revenue RMB 1.75–1.95bn (below the company's target floor) → 2027 revenue RMB 2.4–2.8bn (+37%~+55%), gross margin 15%→16–19%, adjusted breakeven on the edge, HVDC small batches; exit P/S 7.5–9x × 2027E revenue (anchors: POWI steady-state 5–6x + growth premium for 40% growth – discount for gross-margin ramp phase; below the company's current forward P/S of 10.6–12.1x, avoiding circular reasoning) |
| Bull | 23% | 40 – 55 (midpoint 47.5) | +46% ~ +101% | Formal Nvidia Kyber PO + DrGaN 15V moving to mass production + 2027 revenue of RMB 3.0–3.2bn with gross margin >20%; ramp math: 2028E revenue of RMB 4.2–4.8bn × P/S 8–10x (conservative growth-stock range with earnings delivered; explicitly not using Navitas's 66.8x option-like pricing) |
External anchor cross-check: the bear case of HK$9–15 is far below the lowest verifiable sell-side target price after the interim report (CMB at HK$74.2, +171%) — the sell-side spectrum has not priced the bear case; this report's bear case is an independent stress assumption (P/E is invalid under delayed breakeven, so only P/S can be used; not directly comparable to sell-side). Morgan Stanley's "Equal-weight" verifiable basis is a target price of HK$95 (first coverage in H2 2025); the circulating HK$69 figure lacks a verified public source and is not cited in this report.
Our forecasts vs. third parties:
| Item | This report | Management guidance | Sell-side (post-interim) |
|---|---|---|---|
| FY2026E revenue | RMB 1.75–1.95bn (+44%~+61%) | Target RMB 2.0–2.5bn (earnings call basis) | CMB ~RMB 2.0bn; Goldman Sachs RMB 2.082bn |
| FY2026E gross margin | 13.5%–15% (reaching 17.4%+ in H2 is challenging) | ~15% (minutes basis) | CMB cut 70bp |
| FY2027E revenue | RMB 2.4–2.8bn (+37%~+55%) | Not quantified | CMB ~RMB 2.45bn; Goldman Sachs RMB 4.013bn |
| FY2027E net profit | –RMB 150m ~ +RMB 100m (edge of breakeven) | Net profit turning positive (minutes basis) | Goldman Sachs EPS RMB 0.40 (~+RMB 370m) |
Conclusion: Fair. Base-case fair value of HK$24–32, with the current price of 27.40 in the middle of the range; margin of safety (base-case floor basis) –12.4%; probability-weighted expectation ~HK$28.5 (+4.0%) — separating quality (global leader + genuine improvement) from price (lowest percentile but no earnings floor): the current price shows no obvious mispricing; upside odds depend on the bull scenario materializing while downside risk is real — neutral waiting for validation is the stance with better odds.
1. Market Size. The global power GaN device market (Yole, Power GaN 2025, device-level basis): USD 355 million in 2024 → approximately USD 3.0 billion by 2030, CAGR of roughly 42%; TrendForce basis: USD 920 million in 2026 (+58%), 2025-2030 CAGR of roughly 44%; the basis cited by Infineon: approximately USD 2.5 billion by 2030 (CAGR 36%). By application: consumer/mobile (mainly fast charging) accounts for >50% by 2030; data center + telecom is the fastest-growing sub-segment (CAGR of roughly 53%, device-level basis approximately USD 380 million by 2030 — note this is device-level, vastly different from system-level/SAM basis; see the demand inflection chain below). The Frost & Sullivan broad-basis figure cited in the company's prospectus (RMB 3.228 billion in 2024 → RMB 50.142 billion by 2028, CAGR 98.5%) is significantly higher than Yole's due to broader product definitions; it is used only as a cross-reference and not adopted. Growth history: approximately USD 83 million in 2021 (TrendForce) → USD 355 million in 2024, three-year CAGR of roughly 62% — the industry has entered a volume ramp-up phase since 2025.
2. Value Chain and Value Distribution. Silicon substrates (commoditized, no bottleneck) → GaN epitaxy (MOCVD) → wafer fabrication → devices/ICs/modules; China controls global supply dominance of gallium raw material (export controls since August 2023), with low upstream value share. The bulk of gross margin resides in the "design + system-level packaging" segment: fabless Power Integrations has a non-GAAP gross margin of 55.1%, Navitas 39.5%, versus IDM Innoscience's 11.6% — the gap is essentially due to revenue structure (consumer at 36%) plus scale effects not yet fully realized, not a business-model disadvantage; the company's 8-inch line delivers +80% die output per wafer vs. 6-inch, -30% unit cost, and 95%+ yield, placing it at the far left of the industry cost curve, with current pricing-for-volume suppressing apparent gross margin. The manufacturing landscape is being reshaped: TSMC announced in July 2025 its exit from GaN foundry by July 31, 2027 (citing "price pressure from Chinese manufacturers"); Navitas has migrated capacity to PSMC (8-inch, 100V in volume production since 2026H1) and added GlobalFoundries (licensed TSMC's 650V process, US domestic capacity) — the foundry model is shrinking but not disappearing; Yole judges the industry is shifting toward IDM dominance (Innoscience/Infineon/TI).
3. Supply-Demand and Competitive Landscape. Twin demand drivers: rising GaN penetration in consumer fast charging (base) + incremental AI data center demand (upside); supply is being released in concentration in 2026-2027 — Innoscience at 30,000-35,000 wafers/month installed by year-end, Infineon 300mm (new fab starting production by end-2027), PSMC 8-inch foundry, GF 200mm; Yole's Power Electronics Industry 2026 has already warned of industry-wide "overcapacity, price pressure, accelerating consolidation"; the consumer price war has driven TSMC's exit and Navitas' voluntary abandonment of mobile/low-end consumer (revenue -27.6% in 2026Q2), while AI data center supply remains tight until 2027. Share basis (must be distinguished): Frost & Sullivan puts Innoscience first in 2023 at 42.4% by device shipments and 33.7% by revenue; Yole's 2023 revenue basis is 31%; based on 2025 revenue of RMB 1.213 billion (≈USD 171 million) ÷ Yole's implied 2025 market of approximately USD 580 million, our own calculation yields approximately 29%. The estimated top-3 concentration exceeds half (inferred; the first tier consists of Innoscience/POWI/Navitas). Barriers to entry: mass production of 8-inch enhancement-mode GaN CMOS-compatible processes (only a few players globally) + patents (two rounds of 337 litigation prove IP is the entry ticket) + capacity capital expenditure (the company's 2026-2027 CapEx of RMB 2.0-3.0 billion) + system-level know-how.
4. Cycles and Regulation. The broader power semiconductor industry is in the late downcycle/bottoming phase (Yole: industry-wide 2025-2031 CAGR of only 7.1%, shifting to consolidation and cost competition), while GaN is a structurally upward sub-segment within it (42-44%), diverging from SiC's downturn (Wolfspeed's bankruptcy restructuring). Regulatory front: the US ITC final determination in 337-TA-1414 (May 2026) found current products non-infringing, with the exclusion order covering only discontinued legacy models; CBP (2026-02-20) cleared the AD-suffix new products — the US channel is clear; China's countermeasures: the Supreme People's Court's final ruling on 2026-06-12 upheld the Suzhou Intermediate Court's China sales ban on certain Infineon GaN products (damages of RMB 10 million), while the Munich court ruled in June 2026 that the company's current products are non-infringing — judicial offense and defense across China, Germany, and the US; China's gallium export controls reinforce domestic manufacturing dominance; sustained policy support for domestic substitution and third-generation semiconductors. Tail risk: if US-China controls escalate to the company itself (Entity List), the overseas narrative breaks (R7).
5. Peer Benchmarking (see the valuation chapter's comparison table). Core difference: the company is a "volume leader" rather than a profit leader — shipments exceed all competitors combined (company basis), yet gross margin is only 1/5 of POWI's; Navitas' revenue is only 1/4 of the company's but it holds the NVIDIA Tier-1 position and US-listed AI valuation elasticity; Infineon's GaN revenue share is <1% but its 300mm is a direct threat to the 8-inch cost advantage; Renesas (Transphorm) had the earliest automotive certifications but a clear scale gap, and its SiC bet has tied up resources.
6. Company Industry Position. Leader, with upward share trend (high-value segment revenue +70%, AI shipments +183%, onsemi/ST reverse-binding its capacity). Moat: the world's only 8-inch GaN volume IDM (far left of cost curve) + full 15V-1200V voltage spectrum + the only Chinese chip company in NVIDIA's 800VDC ecosystem + a cleared US judicial channel. Note on share basis divergence: the company's cited Frost & Sullivan basis (42.4% by shipments) and Yole's revenue basis (31-29%) coexist; this report uniformly adopts a revenue basis of approximately 29-31% with a footnote.
7. Quantified Demand Inflection Chain (800V HVDC). This is the main engine of the industry's migration from consumer to high-value, and the decisive factor for the company's valuation: driver variable — AI rack power density rose from 120kW (GB200) to 600kW (Rubin Ultra NVL576/Kyber, shipping 2027H2) within 24 months; the 54V architecture hits physical limits at 400kW+ racks (a 1MW rack requires 200kg of copper busbar), making 800VDC the only solution; step-change in unit content — PSUs move from 5kW→30kW, SiC/GaN unit content value rises from a few dollars per rack to the order of ~USD 200/kW (Navitas management basis), with GaN handling the second/three-stage power conversion from 800V→50V/12V and high-density PSUs; penetration ramp — 2025: NVIDIA officially announced five GaN partners (TI/Navitas/Infineon/Innoscience/onsemi) + sampling → 2026: small-batch secondary power, tertiary power sampling (company basis; AI chip shipments +183%) → 2027: Kyber volume production, first commercial adoption per Yole (device revenue penetration still <5%) → 2028: steep ramp as Rubin Ultra scales; Chinese CSPs (ByteDance/Tencent/Alibaba) launch 800VDC retrofits in parallel. Company share — the only Chinese IDM among the five, the industry's only full-chain (800V→1V) GaN supplier, with devices adopted in power designs by more than half of NVIDIA's partners (per GTC 2026 disclosure); basis controversy and suppressive factors — the TAM denominator ranges from Yole's device basis of USD 380 million to Navitas' SAM basis of USD 3.5 billion (GaN roughly half), a difference of one order of magnitude, stemming from device vs. system, and whether SiC and grid-side are included; Navitas has co-developed with NVIDIA to the second-generation 24kW power board (roughly one generation ahead of the company), and Infineon's EUR 1.1 billion 300mm new fab starts production by end-2027 — the inflection is real, but the share and timing the company can capture are not yet locked in. Conclusion: this is a genuine structural demand inflection point (with a complete quantifiable chain), but pricing it at the current level requires discounting for both "lagging competitive positioning" and "resolution not until 2027" — this is precisely the source of the gap between the bull/bear scenarios of HK$40-55 vs. HK$9-15.
Overall rating: Neutral, confidence 0.45, on a 12-month horizon. The global GaN leader's industry position and 8-inch cost barrier are real, fundamental marginal improvement is real, and valuation percentile is the lowest since listing — but the current price of HK$27.40 already sits in the middle of the baseline fair value range (HK$24-32), with a probability-weighted expected return of roughly +4.0% and no obvious mispricing; upside elasticity depends on NVIDIA's formal orders materializing (2026Q4-2027Q2 window) and FY2026 annual gross margin validation, while downside risks stem from lagging competitive positioning, placement dilution triggered by delayed turnaround to profit, and low-cost share supply of approximately 34% of capital.
Strategy: Holders may continue holding to await a right-side signal; non-holders need neither chase high nor panic-sell — reassess below HK$24 (baseline floor broken) or when bear-case evidence becomes explicit (annual gross margin <14%, quarterly insider selling at the 30-million-share level, discounted placement announcement); above HK$32 (baseline ceiling), bull-scenario pricing activates, contingent on order evidence.
Risk alerts (downside): Infineon's 300mm ramping on schedule (EUR 1.1 billion new fab starting production by end-2027) eroding the cost advantage; Navitas/Infineon locking in Kyber BOM first; inventory impairment giveback amid a prolonged consumer price war (inventory of RMB 1.069 billion, finished goods RMB 785 million); discounted placement triggered by delayed 2027 turnaround (dilution of 9%-17%); US-China control escalation to the company's entity; concentrated selling by the CMB-affiliated group/chairman-related parties.
Catalysts (upside): NVIDIA 800V formal PO/supply agreement; MSCI November review (announced 2026-11-11); Hang Seng Tech Index expansion review (late November 2026); FY2026 annual gross margin ≥15% with reiterated turnaround to profit (2027-03); capacity installation of 30,000-35,000 wafers/month delivered (end-2026); USPTO declaring Infineon's remaining '481 claims invalid (2027H1-H2); onsemi MoU converted to a formal purchase agreement.
This report is based on a frozen price anchor at the 2026-10-30 close (HK$27.40) and public information as of 2026-10-31. Prices, market caps, and multiples are timestamped; exchange rate is RMB 1 = HKD 1.1796 (2026-10-31). Failure conditions for key assumptions and catalysts are listed in the monitoring checklist; sell-side target prices reflect individual analyst estimates, Bloomberg consensus details were not obtained, and market expectation judgments are based on ranges rather than precise anchors.